363 related articles for article (PubMed ID: 12795331)
21. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
22. A score to predict short-term risk of COPD exacerbations (SCOPEX).
Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
[TBL] [Abstract][Full Text] [Related]
23. Determining prognosis in acute exacerbation of COPD.
Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
[TBL] [Abstract][Full Text] [Related]
24. Toward a consensus definition for COPD exacerbations.
Rodriguez-Roisin R
Chest; 2000 May; 117(5 Suppl 2):398S-401S. PubMed ID: 10843984
[TBL] [Abstract][Full Text] [Related]
25. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
26. Trends in moderate and severe exacerbations among COPD patients in the UK from 2005 to 2013.
Oshagbemi OA; Keene SJ; Driessen JHM; Jordan R; Wouters EFM; de Boer A; de Vries F; Franssen FME
Respir Med; 2018 Nov; 144():1-6. PubMed ID: 30366578
[TBL] [Abstract][Full Text] [Related]
27. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
Jiang M; Ma JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
[TBL] [Abstract][Full Text] [Related]
28. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
[TBL] [Abstract][Full Text] [Related]
29. Exacerbations of COPD.
Pavord ID; Jones PW; Burgel PR; Rabe KF
Int J Chron Obstruct Pulmon Dis; 2016; 11 Spec Iss(Spec Iss):21-30. PubMed ID: 26937187
[TBL] [Abstract][Full Text] [Related]
30. The impact of using different symptom-based exacerbation algorithms in patients with COPD.
Trappenburg JC; van Deventer AC; Troosters T; Verheij TJ; Schrijvers AJ; Lammers JW; Monninkhof EM
Eur Respir J; 2011 May; 37(5):1260-8. PubMed ID: 21177839
[TBL] [Abstract][Full Text] [Related]
31. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.
Seemungal TA; Donaldson GC; Bhowmik A; Jeffries DJ; Wedzicha JA
Am J Respir Crit Care Med; 2000 May; 161(5):1608-13. PubMed ID: 10806163
[TBL] [Abstract][Full Text] [Related]
32. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological relationships between the common cold and exacerbation frequency in COPD.
Hurst JR; Donaldson GC; Wilkinson TM; Perera WR; Wedzicha JA
Eur Respir J; 2005 Nov; 26(5):846-52. PubMed ID: 16264045
[TBL] [Abstract][Full Text] [Related]
34. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
[TBL] [Abstract][Full Text] [Related]
35. [The associations between comorbidity and exacerbation risk in patients with chronic obstructive pulmonary disease].
Huang YL; Mao B; Mim J; Li GH; Zheng YQ; Wu LH; Wang SJ; Qu B; Fu JJ
Zhonghua Jie He He Hu Xi Za Zhi; 2018 May; 41(5):349-354. PubMed ID: 29747278
[No Abstract] [Full Text] [Related]
36. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
[TBL] [Abstract][Full Text] [Related]
37. Patterns and characterization of COPD exacerbations using real-time data collection.
Ejiofor SI; Stolk J; Fernandez P; Stockley RA
Int J Chron Obstruct Pulmon Dis; 2017; 12():427-434. PubMed ID: 28182151
[TBL] [Abstract][Full Text] [Related]
38. Acute exacerbations of COPD: risk factors for failure and relapse.
Mantero M; Rogliani P; Di Pasquale M; Polverino E; Crisafulli E; Guerrero M; Gramegna A; Cazzola M; Blasi F
Int J Chron Obstruct Pulmon Dis; 2017; 12():2687-2693. PubMed ID: 28932112
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
Wilson R; Anzueto A; Miravitlles M; Arvis P; Haverstock D; Trajanovic M; Sethi S
Int J Chron Obstruct Pulmon Dis; 2015; 10():985-93. PubMed ID: 26082623
[TBL] [Abstract][Full Text] [Related]
40. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]